NEULAND LABORATORIES LTD.
Cah Flow
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|
Profit Before Tax | 2157.46 | 821.63 | 1053.34 | 529.23 | 203.37 |
Adjustment | 760.53 | 663.04 | 400.85 | 582.76 | 391.06 |
Changes In working Capital | -109.60 | -675.85 | 492.17 | -491.73 | 154.70 |
Cash Flow after changes in Working Capital | 2808.40 | 808.82 | 1946.35 | 620.25 | 749.14 |
Cash Flow from Operating Activities | 2372.12 | 603.89 | 1893.62 | 573.41 | 699.07 |
Cash Flow from Investing Activities | -614.99 | -955.16 | -844.24 | -486.80 | -772.29 |
Cash Flow from Financing Activities | -1357.96 | 377.22 | -1136.60 | -54.80 | 119.77 |
Net Cash Inflow / Outflow | 399.18 | 25.94 | -87.22 | 31.81 | 46.55 |
Opening Cash & Cash Equivalents | 50.91 | 24.36 | 112.04 | 79.38 | 32.88 |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | NA | NA | NA | NA | NA |
Cash & Cash Equivalent of Subsidiaries under liquidations | NA | NA | NA | NA | NA |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | NA | NA | NA | NA | NA |
Effect of Foreign Exchange Fluctuations | 4.07 | 0.62 | -0.46 | 0.85 | -0.05 |
Closing Cash & Cash Equivalent | 454.16 | 50.91 | 24.36 | 112.04 | 79.38 |